Insmed, Inc. (NASDAQ:INSM)

NuclearSteve (51.91) Submitted: 4/12/2013 2:10:22 PM : Start Price: $7.56 INSM Score: +38.89

New Baker Brothers Holding.

scrubs62074 (79.85) Submitted: 2/12/2013 2:56:15 PM : Start Price: $6.07 INSM Score: +69.81

High Volume Breakout on 02/12/13

solanZRaider (< 20) Submitted: 6/26/2012 4:07:27 PM : Start Price: $3.18 INSM Score: +216.70

ZZ Top

nvcrader (< 20) Submitted: 1/21/2012 2:49:47 AM : Start Price: $5.03 INSM Score: +89.76

UPDATE 2-FDA lifts hold on Insmed's lung disease drug, shares jump

justinjohngalt (< 20) Submitted: 7/15/2010 1:20:05 PM : Start Price: $6.84 INSM Score: +6.53

Cash

mhurdle (< 20) Submitted: 6/21/2009 9:24:46 PM : Start Price: $24.70 INSM Score: -139.90

attractive economics; strong product

BeatBuffet (71.13) Submitted: 6/12/2009 9:42:06 AM : Start Price: $21.30 INSM Score: -127.53

Because people eat and drink too much sugar and they have a break-through medicine that treats insulin resistance, for which, they just cleared up legal liabilities and gained the right to market their product to a broader spectrum of patients. I bought it close to a buck, just sold it to hold another position, will hold it again soon. This is a long-term pick IMO.

utern (49.07) Submitted: 3/6/2007 8:38:49 PM : Start Price: $15.00 INSM Score: -117.83

Just got out from under a lwsuit with DNA seemingly unscathed. They have a novel interactive drug that has potential usage against ALS Diabetes and may more.

imagineimu (< 20) Submitted: 3/3/2007 9:11:07 AM : Start Price: $15.60 INSM Score: -58.60

This stock has been under pressure do to the on going litigation with trca/dna. Once this is over, which it appears it is close being it should increase substantially. INSM has orphan drug status and should get European market approval within the next 30 days and thus locking out any competitor for 10 years, it is also being tested for ALS uses by the Italian government and if positive results come out iplex could be the next billion dollar drug.

obiwankenobe1250 (87.12) Submitted: 3/3/2007 8:51:47 AM : Start Price: $15.60 INSM Score: +58.60

Voraciously consuming an inordinate amount of cash relative to its revenues. Long term prospects had better pan out, because the near term looks pretty dismal. And besides, downwithpumpers provided the tip.

theonlyslacker (64.79) Submitted: 3/2/2007 3:08:38 PM : Start Price: $15.70 INSM Score: -57.67

Have picked this stock since below a dollar. Company has numerous possible indications for their drugs in major categories. Price is risk weighted heavily as a result of financials and litigation with larger companies (DNA/TRCA). Two continuation in scheduled court dates lead one to speculate there is a settlement in the works. If you remove the cloud of litigation raising money should not be difficult assuming part of any settlement does not include capital.

mcob337 (< 20) Submitted: 2/22/2007 11:25:58 PM : Start Price: $15.00 INSM Score: -48.92

Letigation holding this winner down.

RBBioContest06 (< 20) Submitted: 5/31/2006 10:31:45 PM : Start Price: $16.50 INSM Score: -74.25

Picked by ferros